Exenatide (Exendin-4): GLP-1 Agonist Mechanism, Clinical Impact, and Evolving Neuroprotective Research

Exenatide, a synthetic GLP1 receptor agonist, has long been a cornerstone in type 2 diabetes management. Beyond its established glycemic control and weight reduction benefits, recent research is exploring its potential in neuroprotection — revealing both promising avenues and unexpected outcomes in Parkinson's disease trials.

For research use only. Not for human consumption.